While less effective than the 7-hydroxylated derivative, neolamellarin A (26) (Figure 3) also demonstrated HIF-1 inhibitory activity in the reporter gene assay based on T47D human breast tumor cells [140] and prompted the synthesis of a series of derivatives to identify the structural requirements underlying the effects towards HIF-1 [142]. Here, HIF1A is linked to breast neoplasm.